Displaying drugs 10226 - 10250 of 10948 in total
Mavrilimumab
Mavrilimumab has been investigated for the treatment of Rheumatoid Arthritis.
Investigational
Matched Description: … Mavrilimumab has been investigated for the treatment of Rheumatoid Arthritis. …
Mizoribine
Mizoribine has been investigated for the treatment of Rheumatoid Arthritis.
Investigational
Matched Description: … Mizoribine has been investigated for the treatment of Rheumatoid Arthritis. …
BMS-582949
BMS-582949 has been investigated for the treatment of Psoriasis.
Investigational
Matched Description: … BMS-582949 has been investigated for the treatment of Psoriasis. …
Doxifluridine
Doxifluridine has been investigated for the treatment of Stomach Cancer.
Investigational
Matched Description: … Doxifluridine has been investigated for the treatment of Stomach Cancer. …
Serlopitant
Serlopitant has been investigated for the treatment of Prurigo Nodularis.
Investigational
Matched Description: … Serlopitant has been investigated for the treatment of Prurigo Nodularis. …
Glyceryl Trioleate
Glyceryl Trioleate has been investigated for the treatment of Adrenoleukodystrophy.
Investigational
Matched Description: … Glyceryl Trioleate has been investigated for the treatment of Adrenoleukodystrophy. …
GFH-925
GFH-925 is an irreversibly covalent inhibitor of KRAS G12C.
Investigational
Matched Description: … GFH-925 is an irreversibly covalent inhibitor of KRAS G12C. …
Icosabutate
Icosabutate is under investigation in clinical trial NCT02373176 ([14C] Icosabutate -A Phase I Absorption, Metabolism and Excretion Study).
Investigational
Matched Description: … Icosabutate is under investigation in clinical trial NCT02373176 ([14C] Icosabutate -A Phase I Absorption …
Tretamine
Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.
Experimental
Matched Description: … Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome …
Agerafenib
Agerafenib is under investigation in clinical trial NCT03052569 (Expanded Access to RXDX-105 for Cancers With RET Alterations).
Investigational
Matched Description: … Agerafenib is under investigation in clinical trial NCT03052569 (Expanded Access to RXDX-105 for Cancers …
Fluoroacetic acid F-18
Fluoroacetic acid F-18 is under investigation in clinical trial NCT01320787 (18-F-Fluoroacetate as PET Imaging Agent).
Investigational
Matched Description: … Fluoroacetic acid F-18 is under investigation in clinical trial NCT01320787 (18-F-Fluoroacetate as PET …
anti-OX40 antibody BMS 986178
A macrocyclic peptide (BMS-986189) with activity in binding and functional assays comparable to a PD-L1 antibody.
Investigational
Matched Description: … A macrocyclic peptide (BMS-986189) with activity in binding and functional assays comparable to a PD-L1 …
MORAb-066
MORAb-066 is a humanized antibody directed against tissue factor (TF). It is being investigated in pancreatic cancer.
Investigational
Matched Description: … It is being investigated in pancreatic cancer. …
Ceftiofur
Ceftiofur is a third generation cephalosporin antibiotic, first described in 1987, and now used in veterinary medicine. It is marketed by pharmaceutical company Zoetis as Excenel, and is the active ingredient in that company's Specramast LC (lactating cow formula) product. It is resistant to hydrolysis by beta-lactamase, and has activity...
Vet approved
Matched Iupac: … (6R,7R)-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-3-[(furan-2-carbonylsulfanyl) …
Matched Description: … Ceftiofur is a third generation cephalosporin antibiotic, first described in 1987, and now used in veterinary ... It is marketed by pharmaceutical company Zoetis as Excenel, and is the active ingredient in that company's ... antibiotic activity, consequently the two compounds are measured together to monitor for antibiotic activity in …
Matched Description: … Ceftiofur is a third generation cephalosporin antibiotic, first described in 1987, and now used in veterinary ... It is marketed by pharmaceutical company Zoetis as Excenel, and is the active ingredient in that company's ... antibiotic activity, consequently the two compounds are measured together to monitor for antibiotic activity in …
Dolcanatide
Dolcanatide has been investigated in Exposure.
Investigational
Matched Description: … Dolcanatide has been investigated in Exposure. …
Methcathinone
Methcathinone is under investigation in clinical trial NCT02617862 (PCI Imaging System in Pediatric Ophthalmology).
Investigational
Matched Description: … Methcathinone is under investigation in clinical trial NCT02617862 (PCI Imaging System in Pediatric Ophthalmology …
Isopropyl beta-D-thiogalactopyranoside
A non-metabolizable galactose analog that induces expression of the LAC operon.
Experimental
Matched Description: … A non-metabolizable galactose analog that induces expression of the LAC operon. …
Adomeglivant
Adomeglivant has been investigated for the basic science of Type 2 Diabetes.
Investigational
Matched Description: … Adomeglivant has been investigated for the basic science of Type 2 Diabetes. …
Dutogliptin
Dutogliptin has been investigated for the treatment of Diabetes Mellitus, Type II.
Investigational
Matched Description: … Dutogliptin has been investigated for the treatment of Diabetes Mellitus, Type II. …
Imidapril
Imidapril has been investigated for the treatment of Kidney, Polycystic, Autosomal Dominant.
Investigational
Matched Description: … Imidapril has been investigated for the treatment of Kidney, Polycystic, Autosomal Dominant. …
MK-0557
MK0557 has been investigated for the treatment of Schizophrenia and Paranoid Schizophrenia.
Investigational
Matched Description: … MK0557 has been investigated for the treatment of Schizophrenia and Paranoid Schizophrenia. …
Salvinorin A
Salvinorin A has been investigated for the basic science of Pharmaceutical Preparations.
Investigational
Matched Iupac: … 10aS,10bR)-9-(acetyloxy)-2-(furan-3-yl)-6a,10b-dimethyl-4,10-dioxo-dodecahydro-1H-naphtho[2,1-c]pyran-7- …
Matched Description: … Salvinorin A has been investigated for the basic science of Pharmaceutical Preparations. …
Matched Description: … Salvinorin A has been investigated for the basic science of Pharmaceutical Preparations. …
BMS-863233
BMS-863233 has been investigated for the treatment of Refractory Hematologic Cancer.
Investigational
Matched Iupac: … 12-chloro-4-[(2S)-pyrrolidin-2-yl]-8-oxa-3,5-diazatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),3,10,12-pentaen …
Matched Description: … BMS-863233 has been investigated for the treatment of Refractory Hematologic Cancer. …
Matched Description: … BMS-863233 has been investigated for the treatment of Refractory Hematologic Cancer. …
Oglemilast
Oglemilast has been investigated for the treatment of Pulmonary Disease, Chronic Obstructive.
Investigational
Matched Iupac: … dichloropyridin-4-yl)-6-(difluoromethoxy)-12-methanesulfonamido-8-oxatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7) …
Matched Description: … Oglemilast has been investigated for the treatment of Pulmonary Disease, Chronic Obstructive. …
Matched Description: … Oglemilast has been investigated for the treatment of Pulmonary Disease, Chronic Obstructive. …
NB-001
NB-001 has been investigated for the treatment of Recurrent Herpes Labialis.
Investigational
Matched Description: … NB-001 has been investigated for the treatment of Recurrent Herpes Labialis. …
Displaying drugs 10226 - 10250 of 10948 in total